96921 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#2COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
#3FOLLISTATIN-LIKE 1 (FSTL1) FOR REPAIRING CARDIAC TISSUE
#4TARGETED PROTEIN DEGRADATION SYSTEM AND USE THEREOF
#5METHODS OF PREPARATION OF SECRETOMES, AND USES THEREOF
#6Heterologous Prime Boost Vaccine
#7ENGINEERED SIRPá VARIANTS AND METHODS OF USE THEREOF
#8MAMMALIAN CELL CULTURE PROCESS FOR RECOMBINANT PROTEIN PRODUCTION
#9DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES
#10DIAGNOSIS OF COLORECTAL CANCER USING TARGETED QUANTIFICATION OF PEPTIDES
#11CHIMERIC CYTOKINE RECEPTOR
#12GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#13RECOMBINANT NUCLEIC ACID MOLECULES AND THEIR USE IN WOUND HEALING
#14SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE CONTAINING MOLECULES USING THE SAME
#15ENGINEERED SIRPa VARIANTS AND METHODS OF USE THEREOF
#16DEGLYCOSYLATED LRG1 GLYCOPROTEIN AND LRG1 GLYCOPROTEIN VARIANT, AND USE THEREOF
#17AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS
#18Collagen-localized immunomodulatory molecules and methods thereof
#19CELL-FREE GLYCOPROTEIN SYNTHESIS (CFGPS) IN PROKARYOTIC CELL LYSATES ENRICHED WITH COMPONENTS FOR GLYCOSYLATION
#20NANOSTRUCTURE COMPRISING MAGNETIC NANOPARTICLES AND TRANSFERRIN FAMILY PROTEIN, METHOD FOR PREPARING THE SAME, AND METHOD FOR ISOLATING OR CONCENTRATING EXTRACELLULAR VESICLES OR PATHOGEN
#21COMPOSITIONS AND METHODS FOR REDUCING CHROMATIN CONTENT OF BIOLOGICAL PREPARATIONS
#22Compositions and methods related to ebolavirus vaccines
#23LEUCINE-RICH ALPHA2 GLYCOPROTEIN COMPOSITION
#24Heterologous Prime Boost Vaccine
#25METHODS OF TREATING OF INFLAMMATORY BOWEL DISEASE AND PARASITE INFECTION
#26Process for the cycloaddition of a (hetero)aryl 1,3-dipole compound with a (hetero)cycloalkyne
#27Compositions and methods related to ebolavirus vaccines
#28Herpesvirus with modified glycoprotein B
#29Method of managing joint pain
#30Method of managing joint pain
#31SUMO AND USES THEREOF
#32Methods for preparing modified von Willebrand Factor
#33Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
#34Methods for preparing modified von Willebrand factor
#35ANTIBODY INHIBITING ACTIVATED RAS IN CELL BY INTERNALIZING INTO CYTOSOL OF CELL, AND USE THEREOF
#36GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#37Rapid and efficient de-glycosylation of glycoproteins
#38Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier
#39RECOMBINANT FOLLISTATIN-FC FUSION PROTEINS AND USE IN TREATING DUCHENNE MUSCULAR DYSTROPHY
#40Method for promoting adipocyte differentiation and obesity-related disease treatment
#41COLLAGEN-LOCALIZED IMMUNOMODULATORY MOLECULES AND METHODS THEREOF
#42PHOSPHODIESTERASE INHIBITORS AND METHODS OF MICROBIAL TREATMENT
#43Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#44Uromodulin for use in prevention and therapy of pathological crystallization
#45Knee pain evaluation and management via WOMAC and KOOS systems
#46Method of managing joint pain
#47Formulation, dosage form and method of reducing knee pain
#48Chemoenzymatic glycoengineering of antibodies and FC fragments thereof
#49Herpesvirus with modified glycoprotein B
#50CHIMERIC ANTIGEN RECEPTORS (CARS) SPECIFIC FOR MUC1 AND METHODS FOR THEIR USE
#51Mechanochemical collagen assembly
#52Method of purification of recombinant osteopontin from micro algae
#53Amino diacids containing peptide modifiers
#54REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS
#55Measurement of glycoprotein
#56Measurement of glycoprotein
#57Method for establishing eukaryotic expression cell line of CD36 mutant gene that encodes CD36 deficiency
#58METHODS OF TREATING INFLAMMATORY BOWEL DISEASE AND PARASITE INFECTION
#59GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#60Therapeutic compositions and methods for treatment of muscle wasting diseases
#61Cell-free glycoprotein synthesis (CFGpS) in prokaryotic cell lysates enriched with components for glycosylation
#62Methods and reagents for diagnosing Sjögren's Syndrome
#63Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
#64Methods for preparing modified von Willebrand factor
#65Protein purification by anion exchange chromatography
#66METHOD FOR MEASURING GLYCOPROTEIN, METHOD FOR EXAMINING LIVER DISEASE, REAGENT FOR QUANTITATIVE DETERMINATION OF GLYCOPROTEIN, AND GLYCAN-MARKER GLYCOPROTEIN AS AN INDEX FOR CLINICAL CONDITIONS OF LIVER DISEASE
#67LABELED GLYCAN AMINO ACID COMPLEXES USEFUL IN LC-MS ANALYSIS AND METHODS OF MAKING THE SAME
#68Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters
#69Fusion protein SLIT2D2-HSA and its use in treatment of sepsis
#70COMPOSITIONS AND METHODS FOR TREATING ALLERGIC INFLAMMATION
#71Viral RNA segments as immunomodulatory agents and vaccine components
#72Sialylated fetuin-A as a marker of immunotherapy efficacy
#73Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
#74Amelioration of chronic kidney disease
#75Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
#76Methods for detecting levels of pigment epithelium-derived factor and antithrombin-III for characterising and/or prognosing prostate cancer
#77Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
#78Evolved sortases and uses thereof
#79AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS
#80POLYMER PARTICLES AND USES THEREOF
#81GLYCOPROTEINS HAVING LIPID MOBILISING PROPERTIES AND THERAPEUTIC APPLICATIONS THEREOF
#82MOLECULAR CONJUGATES COMPRISING HUMAN MONOCLONAL ANTIBODIES TO DENDRITIC CELLS
#83BREAST-CANCER DETERMINATION METHOD
#84Mechanochemical collagen assembly
#85GLYCOPROTEINS HAVING LIPID MOBILISING PROPERTIES AND THERAPEUTIC APPLICATIONS THEREOF
#86Methods of treating and preventing infections and associated conditions
#87Compositions and methods for diagnosing and treating hyperthyroidism in companion animals
#88Compositions of, and methods for, alpha-1 antitrypsin Fc fusion molecules
#89Exosomes With Transferrin Peptides
#90Botulinum Neurotoxin E Receptors and Uses Thereof
#91Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases
#92Protein purification by anion exchange chromatography
#93Non-natural MIC proteins
#94ISOLATION OF FACTOR H FROM FRACTION I PASTE
#95GLYCOPROTEINS HAVING LIPID MOBILIZING PROPERTIES AND THERAPEUTIC USES THEREOF
#96Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#97NOVEL AGENTS FOR THE PREVENTION OF LEISHMANIASIS
#98Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver disease
#99Monoclonal antibodies to dendritic cells
#100N-LINKED GLYCAN BIOSYNTHESIS MODULATORS
#101Compositions of, and methods for, alpha-1 anti trypsin Fc fusion molecules
#102Methods of using molecular conjugates comprising monoclonal antibodies to dendritic cells
#103Non-natural MIC proteins
#104Regulation of Integrin Surface Expression
#105Polymer Particles and Uses Thereof
#106COMPOSITIONS, METHODS AND USES FOR TREATING BACTERIAL INFECTIONS
#107Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#108Glycoproteins Having Lipid Mobilising Properties and Therapeutic Applications Thereof
#109COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING MYCOBACTERIAL INFECTIONS
#110Botulinum neurotoxin E receptors and uses thereof
#111Regulation of integrin surface expression
#112Production of proteins carrying oligomannose or human-like glycans in yeast and methods of use thereof
#113Methods for isolation and analysis of sialylated and phosphorylated peptides
#114INHIBITION OF ALPHA-2 HS GLYCOPROTEIN (AHSG/FETUIN) IN OBESITY AND INSULIN CONTROL OF GLUCOSE HOMEOSTASIS
#115Agents for the prevention of
#116Ethanol dependence of alpha1 antitrypsin C-terminal lys truncation by basic carboxypeptidases
#117Production of Proteins Carrying Oligomannose or Human-Like Glycans in Yeast and Methods of Use Thereof
#118Glycoproteins having lipid mobilising properties and therapeutic applications thereof
#119Alpha 1-acid glycoprotein, alpha 2-HS glycoprotein, alpha 1-antitrypsin, and fragments thereof induce apoptosis in cancer cell lines
#120Purification method
#121Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections